Clinical course of progressive multiple sclerosis in Brazilian patients

Neuroepidemiology. 2006;26(4):233-9. doi: 10.1159/000093379. Epub 2006 May 16.

Abstract

Objective: To describe the clinical course and outcome of multiple sclerosis with progressive onset in Brazilian patients. A total of 238 medical records were reviewed, 26 cases (10.9%) fulfilled Thompson criteria (2000), and 5.80% classified as primary progressive and 5.04% relapsing progressive according to Lublin and Reingold.

Study population: 19 Caucasians and 7 non-Caucasians; male:female ratio 1.2:1, mean age at onset was 34 +/- 7.9 years.

Results: Non-Caucasian patients had earlier onset of disease. The most common manifestations at onset were pyramidal and cerebellar (89% and 34.6%). After 11.3 +/- 6.35 years of disease more than 50% of the patients had involvement of most of their functional systems. No statistically significant differences were observed between the subgroups.

Conclusion: The clinical course and outcome of progressive multiple sclerosis in Brazil, a tropical country with low prevalence, were very similar to those in the multiple sclerosis high prevalence areas.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Cross-Cultural Comparison
  • Disability Evaluation
  • Female
  • Humans
  • Male
  • Multiple Sclerosis, Chronic Progressive / diagnosis
  • Multiple Sclerosis, Chronic Progressive / drug therapy
  • Multiple Sclerosis, Chronic Progressive / epidemiology*
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting / epidemiology*
  • Neurologic Examination
  • Outcome Assessment, Health Care
  • Retrospective Studies
  • Tropical Climate

Substances

  • Adrenal Cortex Hormones